<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="sca2" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">sca2</book-part-id>
      <title-group>
        <title>Spinocerebellar Ataxia Type 2</title>
        <alt-title alt-title-type="alt-title">Synonym: SCA2</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Pulst</surname>
            <given-names>Stefan M</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Department of Neurology<break/>University of Utah<break/>Salt Lake City, Utah</aff>
          <email>stefan.pulst@hsc.utah.edu</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>23</day>
          <month>10</month>
          <year>1998</year>
        </date>
        <date date-type="updated">
          <day>12</day>
          <month>11</month>
          <year>2015</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="sca1" document-type="chapter">Spinocerebellar Ataxia Type 1</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="sca3" document-type="chapter">Spinocerebellar Ataxia Type 3</related-object>
      <abstract id="sca2.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Spinocerebellar ataxia type 2 (SCA2) is characterized by progressive cerebellar ataxia, including nystagmus, slow saccadic eye movements and, in some individuals, ophthalmoparesis or parkinsonism. Pyramidal findings are present; deep tendon reflexes are brisk early on and absent later in the course. Age of onset is typically in the fourth decade with a ten- to 15-year disease duration.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of SCA2 rests on the use of molecular genetic testing to detect an abnormal CAG trinucleotide repeat expansion in <italic toggle="yes">ATXN2</italic>. Affected individuals have alleles with 33 or more CAG trinucleotide repeats. Such testing detects nearly 100% of affected individuals.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Management is supportive. Affected individuals should maintain activity. Canes and walkers help prevent falls; grab bars, raised toilet seats, and ramps to accommodate motorized chairs may be necessary. Speech therapy and communication devices such as writing pads and computer-based devices may benefit those with dysarthria. Weighted eating utensils and dressing hooks help maintain a sense of independence. When dysphagia becomes troublesome, video swallowing studies can identify the consistency of food least likely to trigger aspiration.</p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> Vitamin supplements are recommended; weight control helps minimize difficulties with ambulation and mobility.</p>
          <p><italic toggle="yes">Surveillance:</italic> Annual examination by a physician experienced in movement disorders and ataxia.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Alcohol and medications known to affect cerebellar function.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>SCA2 is inherited in an autosomal dominant manner. Offspring of an affected individual have a 50% chance of inheriting the causative CAG trinucleotide repeat expansion. The repeat may expand significantly, especially when transmitted by the father. Prenatal testing for pregnancies at increased risk is possible if the diagnosis has been established by molecular genetic testing in an affected family member.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="sca2.Diagnosis">
        <title>Diagnosis</title>
        <sec id="sca2.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Spinocerebellar ataxia type 2 (SCA2) <bold>should be suspected</bold> in individuals with</p>
          <list list-type="bullet">
            <list-item>
              <p>Slowly progressive ataxia and dysarthria</p>
            </list-item>
            <list-item>
              <p>Nystagmus and slow saccadic eye movements</p>
            </list-item>
            <list-item>
              <p>Family history consistent with autosomal dominant inheritance</p>
            </list-item>
          </list>
        </sec>
        <sec id="sca2.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of SCA2 <bold>is established</bold> in a proband with identification of a heterozygous pathogenic variant in <italic toggle="yes">ATXN2</italic> (see <xref ref-type="table" rid="sca2.T.molecular_genetic_testing_used_in">Table 1</xref>). The clinical features of SCA2 do not allow diagnosis with certainty; thus, diagnosis depends on molecular genetic testing.</p>
          <p>Molecular testing approaches can include <bold>CAG-repeat testing</bold>, use of a <bold>multi-gene panel</bold>, and <bold>more comprehensive</bold>
<bold>genomic testing</bold>.</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>CAG-repeat testing.</bold> CAG-repeat genotyping for the CAG repeat in <italic toggle="yes">ATXN2</italic> is performed first.</p>
            </list-item>
            <list-item>
              <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">ATXN2</italic> CAG-repeat analysis and other genes of interest (see <xref ref-type="sec" rid="sca2.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: The genes included and sensitivity of multi-gene panels vary by laboratory and over time.</p>
              <p>For more information on multi-gene panels click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.MultiGene_Panels" object-type="sec">here</related-object>.</p>
            </list-item>
            <list-item>
              <p><bold>More comprehensive genomic testing</bold> (when available) including exome sequencing, genome sequencing, and mitochondrial sequencing may be considered if single-gene testing (and/or use of a multi-gene panel) fails to confirm the diagnosis in an individual with features of SCA2. For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
            </list-item>
          </list>
          <p>
            <bold>Allele sizes</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Normal allele.</bold> Alleles with 31 or fewer CAG repeats</p>
            </list-item>
            <list-item>
              <p><bold>Intermediate allele of uncertain clinical significance.</bold> Alleles with 32 repeats are uncommon; correlation with clinical findings and family history may be helpful.</p>
            </list-item>
            <list-item>
              <p><bold>Pathogenic allele.</bold> Alleles with 33 or more pure CAG repeats or repeats interrupted by a CAA repeat (see Note) [<xref ref-type="bibr" rid="sca2.REF.pulst.1996.269">Pulst et al 1996</xref>, <xref ref-type="bibr" rid="sca2.REF.charles.2007.1970">Charles et al 2007</xref>]:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Alleles of 33 CAG repeats are considered "late onset" (after age 50 years).</p>
                </list-item>
                <list-item>
                  <p>The most common disease-causing alleles have 37 to 39 repeats. Extreme CAG repeat expansion (&#x0003e;200) has been reported [<xref ref-type="bibr" rid="sca2.REF.babovicvuksanovic.1998.383">Babovic-Vuksanovic et al 1998</xref>] (see <xref ref-type="sec" rid="sca2.Anticipation">Anticipation</xref>).</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p>Note: Interruption of a CAG expanded allele by a CAA repeat does not mitigate the pathogenicity of the repeat size because CAA codes for glutamine as well [<xref ref-type="bibr" rid="sca2.REF.costanziporrini.2000.491">Costanzi-Porrini et al 2000</xref>]; however, the interruption may enhance the meiotic stability of the repeat [<xref ref-type="bibr" rid="sca2.REF.choudhry.2001.2437">Choudhry et al 2001</xref>]. Conversely, the lack of CAA interruption in some expanded alleles may increase the instability of the expansion and therefore increase the risk of transmission of a larger expansion to offspring, who may become symptomatic.</p>
          <table-wrap id="sca2.T.molecular_genetic_testing_used_in" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Molecular Genetic Testing Used in SCA2</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_sca2.T.molecular_genetic_testing_used_in_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_sca2.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_sca2.T.molecular_genetic_testing_used_in_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_sca2.T.molecular_genetic_testing_used_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">ATXN2</italic>
                  </td>
                  <td headers="hd_h_sca2.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Targeted analysis for pathogenic variants&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_sca2.T.molecular_genetic_testing_used_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">~100%</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="sca2.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="sca2" object-id="sca2.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="sca2.TF.1.2">
                <label>2. </label>
                <p>Detects abnormal number of CAG trinucleotide repeats. PCR amplification detects smaller CAG trinucleotide repeat expansions up to ~100 repeats. Southern blotting is required to detect highly expanded CAG trinucleotide repeat expansions (&#x0003e;100 repeats) and may be indicated in symptomatic infants and children [<xref ref-type="bibr" rid="sca2.REF.mao.2002.338">Mao et al 2002</xref>].</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p>Note: Testing individuals with a positive family history of ataxia has a much higher yield than testing individuals with ataxia without an obvious family history.</p>
          <list list-type="bullet">
            <list-item>
              <p>In the series reported by <xref ref-type="bibr" rid="sca2.REF.riess.1997.59">Riess et al [1997]</xref> only two of 842 affected individuals without a family history of ataxia had an <italic toggle="yes">ATXN2</italic> expansion in the abnormal range (41 and 49 repeats).</p>
            </list-item>
            <list-item>
              <p>In the series reported by <xref ref-type="bibr" rid="sca2.REF.cancel.1997.709">Cancel et al [1997]</xref> only two of 90 individuals with olivopontocerebellar atrophy without a known family history had an <italic toggle="yes">ATXN2</italic> expansion in the abnormal range (37 and 39 repeats).</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec id="sca2.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="sca2.Clinical_Description">
          <title>Clinical Description</title>
          <p>Spinocerebellar ataxia type 2 (SCA2) is characterized by slowly progressive ataxia and dysarthria associated with the ocular findings of nystagmus, slow saccadic eye movements, and in some individuals, ophthalmoparesis. Tendon reflexes are brisk during the first years of life, but absent later. Mean age of onset is typically in the fourth decade with a ten- to 15-year disease duration. The disease is more rapidly progressive when onset occurs before age 20 years.</p>
          <p>In the original study from Cuba, the earliest symptoms included gait ataxia often accompanied by leg cramps [<xref ref-type="bibr" rid="sca2.REF.orozco_diaz.1990.1369">Orozco Diaz et al 1990</xref>]. More than 50% of affected individuals developed a kinetic or postural tremor, decreased muscle tone, decreased tendon reflexes, and abnormal eye movements with slowed saccades progressing to supranuclear ophthalmoplegia. Detailed analyses of the eye movement abnormalities have been reported [<xref ref-type="bibr" rid="sca2.REF.engel.2004.778">Engel et al 2004</xref>, <xref ref-type="bibr" rid="sca2.REF.vel_zquezp_rez.2004.444">Vel&#x000e1;zquez-P&#x000e9;rez et al 2004</xref>].</p>
          <p>In individuals with molecularly confirmed <italic toggle="yes">ATXN2</italic>, <xref ref-type="bibr" rid="sca2.REF.geschwind.1997b.842">Geschwind et al [1997b]</xref> found almost universal presence of cerebellar ataxia and slow saccadic eye movements in affected individuals, as well as a relatively high incidence of dystonia or chorea (38%) and dementia (37%). Mild, primarily cerebellar symptoms appeared to segregate in some families, whereas others had an early onset with dementia and chorea.</p>
          <p>Similar findings were also reported by <xref ref-type="bibr" rid="sca2.REF.cancel.1997.709">Cancel et al [1997]</xref> in a series of 111 individuals from 32 families of diverse origins. Slow eye movements were seen in 56%, fasciculations in 25%, and dystonia in 9%. The authors also correlated these findings with disease duration and increasing CAG repeat length.</p>
          <p>An SCA2 phenotype that includes L-dopa-responsive parkinsonism has been reported [<xref ref-type="bibr" rid="sca2.REF.furtado.2002.1625">Furtado et al 2002</xref>, <xref ref-type="bibr" rid="sca2.REF.payami.2003.425">Payami et al 2003</xref>, <xref ref-type="bibr" rid="sca2.REF.infante.2004.848">Infante et al 2004</xref>, <xref ref-type="bibr" rid="sca2.REF.lu.2004.35">Lu et al 2004</xref>, <xref ref-type="bibr" rid="sca2.REF.charles.2007.1970">Charles et al 2007</xref>].</p>
          <p><bold>Neuropathology.</bold> Seven post-mortem examinations have been reported in the Holguin population of Cuba [<xref ref-type="bibr" rid="sca2.REF.orozco.1989.37">Orozco et al 1989</xref>]. A marked reduction in the number of cerebellar Purkinje cells was observed. In silver preparations, Purkinje cell dendrites had poor arborization and torpedo-like formation of their axons as they passed through the granular layer. Parallel fibers were scanty. Granule cells were decreased in number, whereas Golgi and basket cells were well preserved, as were neurons in the dentate and other cerebellar nuclei. In the brain stem, marked neuronal loss in the inferior olive and pontocerebellar nuclei was observed. Six of seven brains also had marked loss in the substantia nigra. In five spinal cords that were available for analysis, marked demyelination was present in the posterior columns and to a lesser degree in the spinocerebellar tracts. Motor neurons and neurons in Clarke's column were reduced in size and number. In the lumbar and sacral segments, anterior and posterior roots were partially demyelinated. Degeneration in the thalamus and reticulotegmental nucleus of the pons has also been reported [<xref ref-type="bibr" rid="sca2.REF.r_b.2003.2257">R&#x000fc;b et al 2003</xref>, <xref ref-type="bibr" rid="sca2.REF.r_b.2004.1258">R&#x000fc;b et al 2004</xref>, <xref ref-type="bibr" rid="sca2.REF.r_b.2005.127">R&#x000fc;b et al 2005</xref>].</p>
          <p>In addition, <xref ref-type="bibr" rid="sca2.REF.orozco.1989.37">Orozco et al [1989]</xref> noted severe gyral atrophy, most prominent in the frontotemporal lobes. The cerebral cortex was thinned, but without neuronal rarefaction. The cerebral white matter was atrophic and gliotic. Degeneration in the pallido-nigro-luysian system mainly involved the substantia nigra. One brain showed patchy loss in parts of the third nerve nuclei. <xref ref-type="bibr" rid="sca2.REF.adams.1997.1163">Adams et al [1997]</xref> reported similar findings in one individual.</p>
          <p>An affected individual with white matter pathology has been described [<xref ref-type="bibr" rid="sca2.REF.armstrong.2005.247">Armstrong et al 2005</xref>].</p>
          <p>Nerve biopsy has shown moderate loss of large myelinated fibers [<xref ref-type="bibr" rid="sca2.REF.filla.1995.793">Filla et al 1995</xref>].</p>
        </sec>
        <sec id="sca2.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p><bold>Probands.</bold> In general, a clear inverse correlation exists between age of onset and CAG repeat length. However, repeat length cannot predict age of onset or disease severity in an individual.</p>
          <list list-type="bullet">
            <list-item>
              <p>The widest range of age of onset is observed among individuals with fewer than 40 CAG repeats. Some individuals with alleles of 33 and 34 repeats have had onset after age 60 years. In one study, the presence of 37 repeats was associated with ages of onset ranging from 20 to 60 years [<xref ref-type="bibr" rid="sca2.REF.pulst.1996.269">Pulst et al 1996</xref>].</p>
            </list-item>
            <list-item>
              <p>For larger repeat sizes, the variability in age of onset is less; repeat sizes greater than 45 are almost always associated with disease onset before age 20 years [<xref ref-type="bibr" rid="sca2.REF.imbert.1996.285">Imbert et al 1996</xref>, <xref ref-type="bibr" rid="sca2.REF.pulst.1996.269">Pulst et al 1996</xref>, <xref ref-type="bibr" rid="sca2.REF.sanpei.1996.277">Sanpei et al 1996</xref>, <xref ref-type="bibr" rid="sca2.REF.cancel.1997.709">Cancel et al 1997</xref>, <xref ref-type="bibr" rid="sca2.REF.geschwind.1997b.842">Geschwind et al 1997b</xref>, <xref ref-type="bibr" rid="sca2.REF.riess.1997.59">Riess et al 1997</xref>, <xref ref-type="bibr" rid="sca2.REF.moretti.2004.392">Moretti et al 2004</xref>].</p>
            </list-item>
          </list>
          <p>The size of the CAG repeat is significantly larger in individuals with dystonia, myoclonus, and myokymia, whereas both CAG length and duration of disease influence the frequency of muscle atrophy, fasciculations, decreased tendon reflexes and vibration sense in the lower extremities, and slow eye movements.</p>
          <p>Homozygosity for an expanded <italic toggle="yes">ATXN2</italic> allele does not appear to influence age of onset [<xref ref-type="bibr" rid="sca2.REF.sanpei.1996.277">Sanpei et al 1996</xref>].</p>
          <p><bold>At-risk individuals.</bold> The age of onset, severity, specific symptoms, and progression of the disease are variable and cannot be predicted by the family history or by molecular genetic (DNA) testing.</p>
        </sec>
        <sec id="sca2.Penetrance">
          <title>Penetrance</title>
          <p>See <xref ref-type="sec" rid="sca2.Establishing_the_Diagnosis">Establishing the Diagnosis</xref>, <bold>Allele sizes</bold> and <xref ref-type="sec" rid="sca2.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</xref>.</p>
        </sec>
        <sec id="sca2.Anticipation">
          <title>Anticipation</title>
          <p>Anticipation (i.e., an increase in the severity of the phenotype and earlier age of onset in later generations) has been observed in SCA2. The tendency of the <italic toggle="yes">ATXN2</italic> CAG repeat to expand as it is transmitted provides a biologic explanation for the earlier age of onset in subsequent generations.</p>
          <p>Paternal transmission of alleles with full penetrance or reduced penetrance is most likely to demonstrate meiotic instability and result in anticipation. In one case report, a man who had 43 repeats and onset of symptoms at age 22 years had an infant with apnea, hypotonia, and dysphagia and an allele of 202 CAG repeats [<xref ref-type="bibr" rid="sca2.REF.babovicvuksanovic.1998.383">Babovic-Vuksanovic et al 1998</xref>]. <xref ref-type="bibr" rid="sca2.REF.mao.2002.338">Mao et al [2002]</xref> identified large expansions in four individuals using a Southern blot assay.</p>
        </sec>
        <sec id="sca2.Nomenclature">
          <title>Nomenclature</title>
          <p>Terms used in the past for SCA2 and other hereditary ataxias include Marie's ataxia, OPCA, and <italic toggle="yes">forme fruste</italic> of Friedreich ataxia. These terms are no longer in use.</p>
        </sec>
        <sec id="sca2.Prevalence">
          <title>Prevalence</title>
          <p><xref ref-type="bibr" rid="sca2.REF.geschwind.1997b.842">Geschwind et al [1997b]</xref> found that in an ethnically varied population in the University of California Los Angeles ataxia clinic, SCA2 accounted for 13% of the autosomal dominant cerebellar ataxias (ADCAs) compared with 6% for <related-object link-type="booklink" source-id="gene" document-id="sca1" document-type="chapter">SCA1</related-object> and 23% for <related-object link-type="booklink" source-id="gene" document-id="sca3" document-type="chapter">SCA3</related-object>.</p>
          <p>In a large series from several ataxia clinics in Germany, SCA2 represented 14% of ADCA pedigrees [<xref ref-type="bibr" rid="sca2.REF.riess.1997.59">Riess et al 1997</xref>].</p>
          <p>A similar percentage (15%) was reported by <xref ref-type="bibr" rid="sca2.REF.cancel.1997.709">Cancel et al [1997]</xref> in 184 families from an ethnically and geographically diverse population.</p>
          <p>In the Baylor College of Medicine ataxia clinic, SCA2 was the most common ADCA (18%) [<xref ref-type="bibr" rid="sca2.REF.lorenzetti.1997.1009">Lorenzetti et al 1997</xref>].</p>
          <p>SCA2 is the most common type of ADCA in Korea [<xref ref-type="bibr" rid="sca2.REF.lee.2003.858">Lee et al 2003</xref>]. (See also <related-object link-type="booklink" source-id="gene" document-id="ataxias" document-type="chapter">Ataxia Overview</related-object>.)</p>
          <p><xref ref-type="bibr" rid="sca2.REF.moseley.1998.1666">Moseley et al [1998]</xref> reported that SCA2 was common in individuals presenting to an ataxia clinic at an academic medical center, representing 15% of persons from families with autosomal dominant inheritance and 2% of simplex cases (i.e., a single occurrence in a family) [<xref ref-type="bibr" rid="sca2.REF.moseley.1998.1666">Moseley et al 1998</xref>].</p>
        </sec>
      </sec>
      <sec id="sca2.Genetically_Related_Allelic_Disorde">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>In addition to ataxia, L-dopa-responsive parkinsonism with or without ataxia has been reported in individuals and families with the <italic toggle="yes">ATXN2</italic> CAG trinucleotide repeat expansion.</p>
      </sec>
      <sec id="sca2.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>It is difficult and often impossible to distinguish spinocerebellar ataxia type 2 (SCA2) from the other hereditary ataxias (see <related-object link-type="booklink" source-id="gene" document-id="ataxias" document-type="chapter">Hereditary Ataxia Overview</related-object>). The differential diagnosis should also include <related-object link-type="booklink" source-id="gene" document-id="parkinson-overview" document-type="chapter">Parkinson disease</related-object> and acquired causes of cerebellar ataxia.</p>
        <p>In six families detected with SCA2 out of 64 families with autosomal dominant cerebellar ataxia (ADCA) of German ancestry, <xref ref-type="bibr" rid="sca2.REF.sch_ls.1997b.1073">Sch&#x000f6;ls et al [1997b]</xref> determined that no specific single feature was sufficient to distinguish SCA2 from the other SCAs; however, slowed saccades, postural and action tremors, myoclonus, and hyporeflexia were more common in individuals with SCA2 than in those with <related-object link-type="booklink" source-id="gene" document-id="sca1" document-type="chapter">SCA1</related-object> and <related-object link-type="booklink" source-id="gene" document-id="sca3" document-type="chapter">SCA3</related-object>.</p>
        <p>Two studies reported quantitative eye movement recordings in individuals with SCA2 and compared them with other ADCAs:</p>
        <list list-type="bullet">
          <list-item>
            <p><xref ref-type="bibr" rid="sca2.REF.b_rk.1996.1497">B&#x000fc;rk et al [1996]</xref> compared several individuals with SCA2 defined by linkage analysis with individuals who had SCA1 or SCA3. Individuals with SCA2 had significantly slower saccadic speed (138&#x000b0;/sec) than individuals with SCA1 (244&#x000b0;/sec) or SCA3 (347&#x000b0;/sec). All eight individuals with SCA2 had saccadic velocities two standard deviations below the mean of a control group.</p>
          </list-item>
          <list-item>
            <p><xref ref-type="bibr" rid="sca2.REF.buttner.1998.1353">Buttner et al [1998]</xref> compared saccades in individuals with <related-object link-type="booklink" source-id="gene" document-id="sca1" document-type="chapter">SCA1</related-object>, SCA2, <related-object link-type="booklink" source-id="gene" document-id="sca3" document-type="chapter">SCA3</related-object>, and <related-object link-type="booklink" source-id="gene" document-id="sca6" document-type="chapter">SCA6</related-object> identified by molecular genetic testing. Individuals with SCA2 had the slowest peak saccadic velocity, ranging from 80 to 295&#x000b0;/sec (normal: &#x0003e;400&#x000b0;/sec). Saccades were also slowed in individuals with SCA1; individuals with SCA3 and SCA6 had normal saccades.</p>
          </list-item>
        </list>
        <p>SCA2 should be in the differential diagnosis of adult-onset sporadic progressive ataxia, multiple system atrophy (MSA, Shy-Drager syndrome; OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/146500">146500</ext-link>), L-dopa-responsive parkinsonism, and atypical <related-object link-type="booklink" source-id="gene" document-id="friedreich" document-type="chapter">Friedreich ataxia</related-object> [<xref ref-type="bibr" rid="sca2.REF.abele.2002.961">Abele et al 2002</xref>].</p>
        <table-wrap id="sca2.T.proportion_of_individuals_with_sc" orientation="portrait" position="anchor">
          <label>Table 2. </label>
          <caption>
            <p>Proportion of Individuals with SCA2 Manifesting Phenotypic Features Compared with Individuals with SCA1, SCA3, and SCA6</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_sca2.T.proportion_of_individuals_with_sc_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Phenotypic Feature</th>
                <th id="hd_h_sca2.T.proportion_of_individuals_with_sc_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">SCA2</th>
                <th id="hd_h_sca2.T.proportion_of_individuals_with_sc_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">SCA1</th>
                <th id="hd_h_sca2.T.proportion_of_individuals_with_sc_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">SCA3</th>
                <th id="hd_h_sca2.T.proportion_of_individuals_with_sc_1_1_1_5" valign="middle" align="left" scope="col" rowspan="1" colspan="1">SCA6</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_sca2.T.proportion_of_individuals_with_sc_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Cerebellar dysfunction</bold>
                </td>
                <td headers="hd_h_sca2.T.proportion_of_individuals_with_sc_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">100%</td>
                <td headers="hd_h_sca2.T.proportion_of_individuals_with_sc_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">100%</td>
                <td headers="hd_h_sca2.T.proportion_of_individuals_with_sc_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">100%</td>
                <td headers="hd_h_sca2.T.proportion_of_individuals_with_sc_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">100%</td>
              </tr>
              <tr>
                <td headers="hd_h_sca2.T.proportion_of_individuals_with_sc_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Reduced saccadic velocity</bold>
                </td>
                <td headers="hd_h_sca2.T.proportion_of_individuals_with_sc_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">71%-92%</td>
                <td headers="hd_h_sca2.T.proportion_of_individuals_with_sc_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">50%</td>
                <td headers="hd_h_sca2.T.proportion_of_individuals_with_sc_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">10%</td>
                <td headers="hd_h_sca2.T.proportion_of_individuals_with_sc_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">0%-6%</td>
              </tr>
              <tr>
                <td headers="hd_h_sca2.T.proportion_of_individuals_with_sc_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Myoclonus</bold>
                </td>
                <td headers="hd_h_sca2.T.proportion_of_individuals_with_sc_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">0%-40%</td>
                <td headers="hd_h_sca2.T.proportion_of_individuals_with_sc_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">0%</td>
                <td headers="hd_h_sca2.T.proportion_of_individuals_with_sc_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">4%</td>
                <td headers="hd_h_sca2.T.proportion_of_individuals_with_sc_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">0%</td>
              </tr>
              <tr>
                <td headers="hd_h_sca2.T.proportion_of_individuals_with_sc_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Dystonia or chorea</bold>
                </td>
                <td headers="hd_h_sca2.T.proportion_of_individuals_with_sc_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">0%-38%</td>
                <td headers="hd_h_sca2.T.proportion_of_individuals_with_sc_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">20%</td>
                <td headers="hd_h_sca2.T.proportion_of_individuals_with_sc_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">8%</td>
                <td headers="hd_h_sca2.T.proportion_of_individuals_with_sc_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">0%-25%</td>
              </tr>
              <tr>
                <td headers="hd_h_sca2.T.proportion_of_individuals_with_sc_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Pyramidal involvement</bold>
                </td>
                <td headers="hd_h_sca2.T.proportion_of_individuals_with_sc_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">29%-31%</td>
                <td headers="hd_h_sca2.T.proportion_of_individuals_with_sc_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">70%</td>
                <td headers="hd_h_sca2.T.proportion_of_individuals_with_sc_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">70%</td>
                <td headers="hd_h_sca2.T.proportion_of_individuals_with_sc_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">33%-44%</td>
              </tr>
              <tr>
                <td headers="hd_h_sca2.T.proportion_of_individuals_with_sc_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Peripheral neuropathy</bold>
                </td>
                <td headers="hd_h_sca2.T.proportion_of_individuals_with_sc_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">44%-94%</td>
                <td headers="hd_h_sca2.T.proportion_of_individuals_with_sc_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">100%</td>
                <td headers="hd_h_sca2.T.proportion_of_individuals_with_sc_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">80%</td>
                <td headers="hd_h_sca2.T.proportion_of_individuals_with_sc_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">16%-44%</td>
              </tr>
              <tr>
                <td headers="hd_h_sca2.T.proportion_of_individuals_with_sc_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Intellectual impairment</bold>
                </td>
                <td headers="hd_h_sca2.T.proportion_of_individuals_with_sc_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">31%-37%</td>
                <td headers="hd_h_sca2.T.proportion_of_individuals_with_sc_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">20%</td>
                <td headers="hd_h_sca2.T.proportion_of_individuals_with_sc_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">5%</td>
                <td headers="hd_h_sca2.T.proportion_of_individuals_with_sc_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">0%</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Percentages modified from <xref ref-type="bibr" rid="sca2.REF.geschwind.1997a.1247">Geschwind et al [1997a]</xref>, <xref ref-type="bibr" rid="sca2.REF.geschwind.1997b.842">Geschwind et al [1997b]</xref>, <xref ref-type="bibr" rid="sca2.REF.sch_ls.1997a.924">Sch&#x000f6;ls et al [1997a]</xref>, and <xref ref-type="bibr" rid="sca2.REF.sch_ls.1997b.1073">Sch&#x000f6;ls et al [1997b]</xref></p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="sca2.Management">
        <title>Management</title>
        <sec id="sca2.Evaluations_Following_Initial_Diagn">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with spinocerebellar ataxia type 2 (SCA2), the following are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Neurologic examination</p>
            </list-item>
            <list-item>
              <p>Ophthalmologic examination</p>
            </list-item>
            <list-item>
              <p>Baseline assessment of cognition</p>
            </list-item>
            <list-item>
              <p>Neuroimaging</p>
            </list-item>
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor</p>
            </list-item>
          </list>
        </sec>
        <sec id="sca2.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Management of individuals remains supportive as no known therapy to delay or halt the progression of the disease exists.</p>
          <p>Although neither exercise nor physical therapy has been shown to stem the progression of incoordination or muscle weakness, individuals should maintain activity.</p>
          <p>Canes and walkers help prevent falls.</p>
          <p>Modification of the home with such conveniences as grab bars, raised toilet seats, and ramps to accommodate motorized chairs may be necessary.</p>
          <p>Speech therapy and communication devices such as writing pads and computer-based devices may benefit those with dysarthria.</p>
          <p>Weighted eating utensils and dressing hooks help maintain a sense of independence.</p>
          <p>When dysphagia becomes troublesome, video esophagrams can identify the consistency of food least likely to trigger aspiration.</p>
          <p>Improvement of severe tremor with thalamic stimulation has been reported in one individual [<xref ref-type="bibr" rid="sca2.REF.pirker.2003.222">Pirker et al 2003</xref>]. Another individual showed improvement with stimulation of the subthalamic nucleus [<xref ref-type="bibr" rid="sca2.REF.freund.2007.732">Freund et al 2007</xref>].</p>
        </sec>
        <sec id="sca2.Prevention_of_Secondary_Complicatio">
          <title>Prevention of Secondary Complications</title>
          <p>No dietary factor has been shown to curtail symptoms; however, vitamin supplements are recommended, particularly if caloric intake is reduced.</p>
          <p>Weight control is important because obesity can exacerbate difficulties with ambulation and mobility.</p>
        </sec>
        <sec id="sca2.Surveillance">
          <title>Surveillance</title>
          <p>Affected individuals should be examined at least annually by a physician experienced in movement disorders and ataxia.</p>
        </sec>
        <sec id="sca2.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Alcohol and medications known to affect cerebellar function should be avoided.</p>
        </sec>
        <sec id="sca2.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="sca2.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="sca2.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
        <sec id="sca2.Other">
          <title>Other</title>
          <p>Tremor-controlling drugs do not work well for cerebellar tremors.</p>
        </sec>
      </sec>
      <sec id="sca2.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="sca2.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Spinocerebellar ataxia type 2 (SCA2) is inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="sca2.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Most individuals diagnosed with SCA2 have an affected parent.</p>
            </list-item>
            <list-item>
              <p>A proband with SCA2 may have the disorder as the result of an expansion of a reduced penetrance allele inherited from an unaffected parent.</p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of apparently asymptomatic parents of a proband include physical examination and consideration of <italic toggle="yes">ATXN2</italic> molecular genetic testing.</p>
            </list-item>
            <list-item>
              <p>Although most individuals diagnosed with SCA2 have an affected parent, the family history may appear to be negative because of failure to recognize the disorder in family members, early death of the parent before the onset of symptoms, or late onset of the disease in the affected parent.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of a proband depends on the genetic status of the parents.</p>
            </list-item>
            <list-item>
              <p>If a parent of the proband has an <italic toggle="yes">ATXN2</italic> CAG trinucleotide repeat expansion, the risk to the sibs is 50%. However, age of onset, severity, specific symptoms, and progression of the disease are variable and cannot be predicted by the family history or the size of the inherited expansion.</p>
            </list-item>
            <list-item>
              <p>When neither parent has an expanded <italic toggle="yes">ATXN2</italic> allele, the risk to the sibs of a proband appears to be low.</p>
            </list-item>
            <list-item>
              <p>If an expanded <italic toggle="yes">ATXN2</italic> allele cannot be detected in the leukocyte DNA of either parent, the risk to sibs is low but greater than that of the general population because of the possibility of germline mosaicism (no instances of germline mosaicism have been reported, although it remains a possibility).</p>
            </list-item>
          </list>
          <p>
            <bold>Offspring of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Each child of an individual with SCA2 has a 50% chance of inheriting an expanded <italic toggle="yes">ATXN2</italic> allele.</p>
            </list-item>
            <list-item>
              <p>Further <italic toggle="yes">ATXN2</italic> CAG trinucleotide repeat expansion may occur when the expanded <italic toggle="yes">ATXN2</italic> allele is transmitted to offspring. This results in <xref ref-type="sec" rid="sca2.Anticipation">anticipation</xref> (an earlier age of onset and more severe disease manifestations in offspring).</p>
            </list-item>
            <list-item>
              <p>Large expansions are almost exclusively observed when the repeat is passed through the paternal germline [<xref ref-type="bibr" rid="sca2.REF.geschwind.1997b.842">Geschwind et al 1997b</xref>, <xref ref-type="bibr" rid="sca2.REF.riess.1997.59">Riess et al 1997</xref>] (see <xref ref-type="sec" rid="sca2.Anticipation">Anticipation</xref>). Nonetheless, the age of onset, severity, specific symptoms, and progression of the disease are variable and cannot be predicted by the family history or the size of the expansion.</p>
            </list-item>
          </list>
          <p>
            <bold>Other family members of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to other family members depends on the genetic status of the proband's parents.</p>
            </list-item>
            <list-item>
              <p>If a parent has the expanded <italic toggle="yes">ATXN2</italic> allele, his or her family members may be at risk.</p>
            </list-item>
          </list>
        </sec>
        <sec id="sca2.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p><bold>At-risk individuals.</bold> The age of onset, severity, specific symptoms, and progression of the disease are variable and cannot be predicted by the family history or results of molecular genetic testing.</p>
          <p><bold>Testing of at-risk asymptomatic adult relatives</bold> of individuals with SCA2 is possible after molecular genetic testing has identified an <italic toggle="yes">ATXN2</italic> CAG trinucleotide repeat expansion in an affected family member. Such testing should be performed in the context of formal genetic counseling. This testing is not useful in predicting age of onset, severity, type of symptoms, or rate of progression in asymptomatic individuals. Testing of asymptomatic at-risk individuals with nonspecific or equivocal symptoms is predictive testing, not diagnostic testing.</p>
          <p><bold>Testing of asymptomatic individuals younger than age 18 years</bold> who are at risk for adult-onset disorders for which no treatment exists is not considered appropriate, primarily because it negates the autonomy of the child with no compelling benefit. Further, concern exists regarding the potential unhealthy adverse effects that such information may have on family dynamics, the risk of discrimination and stigmatization in the future, and the anxiety that such information may cause.</p>
          <p>In a family with an established diagnosis of SCA2, it is appropriate to consider testing symptomatic individuals regardless of age.</p>
          <p>For more information, see the National Society of Genetic Counselors <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://nsgc.org/p/bl/et/blogid=47&#x00026;blogaid=28">position statement</ext-link> on genetic testing of minors for adult-onset conditions and the American Academy of Pediatrics and American College of Medical Genetics and Genomics <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf">policy statement</ext-link>: ethical and policy issues in genetic testing and screening of children.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="sca2.Prenatal_Testing_and_Preimplantatio">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once an <italic toggle="yes">ATXN2</italic> CAG trinucleotide repeat expansion has been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for SCA2 are possible.</p>
          <p>Note: Prenatal testing must take into account the possibility of a highly expanded <italic toggle="yes">ATXN2</italic> allele [<xref ref-type="bibr" rid="sca2.REF.babovicvuksanovic.1998.383">Babovic-Vuksanovic et al 1998</xref>].</p>
          <p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="sca2.Resources">
        <title>Resources</title>
      </sec>
      <sec id="sca2.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Benign variants.</bold> Normal alleles have 31 or fewer CAG repeats. The two normal alleles, which account for more than 95% of alleles in most studies, have 22 and 23 CAG repeats [<xref ref-type="bibr" rid="sca2.REF.pulst.1996.269">Pulst et al 1996</xref>, <xref ref-type="bibr" rid="sca2.REF.sanpei.1996.277">Sanpei et al 1996</xref>, <xref ref-type="bibr" rid="sca2.REF.riess.1997.59">Riess et al 1997</xref>].</p>
        <p>Normal alleles typically show one or two CAA interruptions. In contrast to the CAT interruptions coding for histidine that are found in <related-object link-type="booklink" source-id="gene" document-id="sca1" document-type="chapter">SCA1</related-object>, the CAA interruptions do not interrupt the glutamine tract at the protein level. The 5' sequence of the <italic toggle="yes">ATXN2</italic> cDNA is extremely GC rich and two potential ATG initiation codons can be identified. The most 5' ATG is located 78 bp downstream of an in-frame stop codon. Usage of this translation initiation site predicts a protein of 140.1 kd. The second ATG, which has a better Kozak consensus sequence, is located just 5' to the CAG repeat and would result in a protein with a relative molecular weight of 125 kd.</p>
        <p><bold>Intermediate allele of uncertain clinical significance.</bold> 32 repeats is an uncommon allele and information is insufficient to classify it as normal or pathogenic.</p>
        <p><bold>Pathogenic variants.</bold> Disease alleles have 33 or more CAG repeats without interruption [<xref ref-type="bibr" rid="sca2.REF.pulst.2005.2297">Pulst et al 2005</xref>].</p>
        <p>Note: Intermediate alleles (i.e., meiotically unstable alleles that expand into an abnormal allele in the subsequent generation) are not reported in SCA2.</p>
        <table-wrap id="sca2.T.atxn2_variants_discussed_in_this" orientation="portrait" position="anchor">
          <label>Table 3. </label>
          <caption>
            <p><italic toggle="yes">ATXN2</italic> Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_sca2.T.atxn2_variants_discussed_in_this_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variant Classification</th>
                <th id="hd_h_sca2.T.atxn2_variants_discussed_in_this_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_sca2.T.atxn2_variants_discussed_in_this_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_sca2.T.atxn2_variants_discussed_in_this_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_sca2.T.atxn2_variants_discussed_in_this_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Benign</bold>
                </td>
                <td headers="hd_h_sca2.T.atxn2_variants_discussed_in_this_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.496_498CAG(&#x02264;31)<break/>(&#x02264;31 CAG repeats)</td>
                <td headers="hd_h_sca2.T.atxn2_variants_discussed_in_this_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Gln166(&#x02264;31)</td>
                <td headers="hd_h_sca2.T.atxn2_variants_discussed_in_this_1_1_1_4" rowspan="2" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_002973.3">NM_002973.3</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_002964.3">NP_002964.3</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_sca2.T.atxn2_variants_discussed_in_this_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Pathogenic</bold>
                </td>
                <td headers="hd_h_sca2.T.atxn2_variants_discussed_in_this_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.496_498CAG(&#x02265;33)<break/>(&#x02265;33 CAG repeats)</td>
                <td headers="hd_h_sca2.T.atxn2_variants_discussed_in_this_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Gln166(&#x02265;33)</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold> The <italic toggle="yes">ATXN2</italic> protein product has been designated ataxin-2 and it is typically 1312 amino acids (22 glutamines) or predicted 1313 amino acids (23 glutamines) [<xref ref-type="bibr" rid="sca2.REF.pulst.1996.269">Pulst et al 1996</xref>, <xref ref-type="bibr" rid="sca2.REF.sanpei.1996.277">Sanpei et al 1996</xref>].</p>
        <p>In brains from unaffected individuals and in brains from individuals with SCA2, ataxin-2 has a cytoplasmic localization. It associates with Golgi membranes [<xref ref-type="bibr" rid="sca2.REF.huynh.2003.1485">Huynh et al 2003</xref>]. Using antibodies to ataxin-2, the expression pattern of ataxin-2 was identical in brains of unaffected individuals and those affected with SCA2 [<xref ref-type="bibr" rid="sca2.REF.huynh.2000.44">Huynh et al 2000</xref>].</p>
        <p>Ataxin-2 interacts with ataxin-2 binding protein 1 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/215272409">NM_001142333.1</ext-link>), a protein containing RNA-recognition motifs [<xref ref-type="bibr" rid="sca2.REF.figueroa.2003.669">Figueroa &#x00026; Pulst 2003</xref>]. Interaction of ataxin-2 with ataxin-2 binding protein suggests involvement of ataxin-2 in mRNA translation or transport [<xref ref-type="bibr" rid="sca2.REF.shibata.2000.1303">Shibata et al 2000</xref>]. Ataxin-2-deficient mice do not develop marked neurodegeneration but show obesity, reduced fertility, and changes in hippocampal plasticity [<xref ref-type="bibr" rid="sca2.REF.kiehl.2006.17">Kiehl et al 2006</xref>, <xref ref-type="bibr" rid="sca2.REF.huynh.2009.e6235">Huynh et al 2009</xref>].</p>
        <p><bold>Abnormal gene product.</bold> The CAG expansion codes for a protein that has an abnormally long stretch of glutamine amino acid residues. The biologic consequence of this abnormal protein is undetermined. A mouse model of SCA2 has been described by <xref ref-type="bibr" rid="sca2.REF.huynh.2000.44">Huynh et al [2000]</xref>. <italic toggle="yes">Atxn2</italic> transgenic mice had accumulation of ataxin-2 in the cytoplasm. Intranuclear aggregates were not observed. In vitro, expression of mutated ataxin-2 causes apoptotic cell death [<xref ref-type="bibr" rid="sca2.REF.huynh.2003.1485">Huynh et al 2003</xref>]. In the <italic toggle="yes">Atxn2</italic> transgenic mouse, ataxin-2 interacts with the inositol-triphosphate receptor type 1 causing abnormally increased Ca++ release from intracellular calcium stores. This can be ameliorated by treatment in vivo with dantrolene prior to onset of symptoms [<xref ref-type="bibr" rid="sca2.REF.liu.2009.9148">Liu et al 2009</xref>].</p>
      </sec>
      <sec id="sca2.References">
        <title>References</title>
        <sec id="sca2.Published_GuidelinesConsensus_State">
          <title>Published Guidelines/Consensus Statements</title>
          <ref-list id="sca2.Published_GuidelinesConsensus_State.reflist0">
            <ref id="sca2.REF1">
              <mixed-citation publication-type="web">Committee on Bioethics, Committee on Genetics, and American College of Medical Genetics and Genomics Social, Ethical, Legal Issues Committee. Ethical and policy issues in genetic testing and screening of children. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf">online</ext-link>. 2013. Accessed 4-14-17.</mixed-citation>
            </ref>
            <ref id="sca2.REF2">
              <mixed-citation publication-type="web">National Society of Genetic Counselors. Position statement on genetic testing of minors for adult-onset disorders. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://nsgc.org/p/bl/et/blogid=47&#x00026;blogaid=28">online</ext-link>. 2012. Accessed 4-14-17.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="sca2.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="sca2.Literature_Cited.reflist0">
            <ref id="sca2.REF.abele.2002.961">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Abele</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burk</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schols</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Besenthal</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dichgans</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zuhlke</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riess</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klockgether</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>The aetiology of sporadic adult-onset ataxia.</article-title>
                <source>Brain</source>
                <volume>125</volume>
                <fpage>961</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11960886</pub-id>
              </element-citation>
            </ref>
            <ref id="sca2.REF.adams.1997.1163">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Adams</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Starkman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pulst</surname>
                    <given-names>SM</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Clinical and molecular analysis of a pedigree of southern Italian ancestry with spinocerebellar ataxia type 2.</article-title>
                <source>Neurology</source>
                <volume>49</volume>
                <fpage>1163</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">9339711</pub-id>
              </element-citation>
            </ref>
            <ref id="sca2.REF.armstrong.2005.247">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Armstrong</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonaventura</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rojo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonzalez</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corral</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nadal</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Volpini</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrer</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Spinocerebellar ataxia type 2 (SCA2) with white matter involvement.</article-title>
                <source>Neurosci Lett</source>
                <volume>381</volume>
                <fpage>247</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">15896478</pub-id>
              </element-citation>
            </ref>
            <ref id="sca2.REF.babovicvuksanovic.1998.383">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Babovic-Vuksanovic</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Snow</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patterson</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michels</surname>
                    <given-names>VV</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Spinocerebellar ataxia type 2 (SCA 2) in an infant with extreme CAG repeat expansion.</article-title>
                <source>Am J Med Genet</source>
                <volume>79</volume>
                <fpage>383</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">9779806</pub-id>
              </element-citation>
            </ref>
            <ref id="sca2.REF.b_rk.1996.1497">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>B&#x000fc;rk</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abele</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fetter</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dichgans</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skalej</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laccone</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Didierjean</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klockgether</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>Autosomal dominant cerebellar ataxia type I clinical features and MRI in families with SCA1, SCA2 and SCA3.</article-title>
                <source>Brain.</source>
                <year>1996</year>
                <volume>119</volume>
                <fpage>1497</fpage>
                <lpage>505</lpage>
                <pub-id pub-id-type="pmid">8931575</pub-id>
              </element-citation>
            </ref>
            <ref id="sca2.REF.buttner.1998.1353">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Buttner</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geschwind</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jen</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perlman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pulst</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baloh</surname>
                    <given-names>RW</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Oculomotor phenotypes in autosomal dominant ataxias.</article-title>
                <source>Arch Neurol</source>
                <volume>55</volume>
                <fpage>1353</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">9779665</pub-id>
              </element-citation>
            </ref>
            <ref id="sca2.REF.cancel.1997.709">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cancel</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Durr</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Didierjean</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imbert</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burk</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lezin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belal</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benomar</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abada-Bendib</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vial</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guimaraes</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chneiweiss</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stevanin</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yvert</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abbas</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saudou</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lebre</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yahyaoui</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hentati</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vernant</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klockgether</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandel</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Agid</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Molecular and clinical correlations in spinocerebellar ataxia 2: a study of 32 families.</article-title>
                <source>Hum Mol Genet</source>
                <volume>6</volume>
                <fpage>709</fpage>
                <lpage>15</lpage>
                <pub-id pub-id-type="pmid">9158145</pub-id>
              </element-citation>
            </ref>
            <ref id="sca2.REF.charles.2007.1970">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Charles</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Camuzat</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benammar</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sellal</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dest&#x000e9;e</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonnet</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lesage</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Ber</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stevanin</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D&#x000fc;rr</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                  <collab>French Parkinson's Disease Genetic Study Group</collab>
                </person-group>
                <article-title>Are interrupted SCA2 CAG repeat expansions responsible for parkinsonism?</article-title>
                <source>Neurology.</source>
                <year>2007</year>
                <volume>69</volume>
                <fpage>1970</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">17568014</pub-id>
              </element-citation>
            </ref>
            <ref id="sca2.REF.choudhry.2001.2437">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Choudhry</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mukerji</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Srivastava</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jain</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brahmachari</surname>
                    <given-names>SK</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>CAG repeat instability at SCA2 locus: anchoring CAA interruptions and linked single nucleotide polymorphisms.</article-title>
                <source>Hum Mol Genet</source>
                <volume>10</volume>
                <fpage>2437</fpage>
                <lpage>46</lpage>
                <pub-id pub-id-type="pmid">11689490</pub-id>
              </element-citation>
            </ref>
            <ref id="sca2.REF.costanziporrini.2000.491">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Costanzi-Porrini</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tessarolo</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abbruzzese</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liguori</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashizawa</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giacanelli</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>An interrupted 34-CAG repeat SCA-2 allele in patients with sporadic spinocerebellar ataxia.</article-title>
                <source>Neurology</source>
                <volume>54</volume>
                <fpage>491</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">10668721</pub-id>
              </element-citation>
            </ref>
            <ref id="sca2.REF.engel.2004.778">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>KC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gomez</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soechting</surname>
                    <given-names>JF</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Deficits in ocular and manual tracking due to episodic ataxia type 2.</article-title>
                <source>Mov Disord</source>
                <volume>19</volume>
                <fpage>778</fpage>
                <lpage>87</lpage>
                <pub-id pub-id-type="pmid">15254935</pub-id>
              </element-citation>
            </ref>
            <ref id="sca2.REF.figueroa.2003.669">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Figueroa</surname>
                    <given-names>KP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pulst</surname>
                    <given-names>SM</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Identification and expression of the gene for human ataxin-2-related protein on chromosome 16.</article-title>
                <source>Exp Neurol</source>
                <volume>184</volume>
                <fpage>669</fpage>
                <lpage>78</lpage>
                <pub-id pub-id-type="pmid">14769358</pub-id>
              </element-citation>
            </ref>
            <ref id="sca2.REF.filla.1995.793">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Filla</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Michele</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Banfi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santoro</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perretti</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cavalcanti</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pianese</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castaldo</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barbieri</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campanella</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cocozza</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Has spinocerebellar ataxia type 2 a distinct phenotype? Genetic and clinical study of an Italian family.</article-title>
                <source>Neurology</source>
                <volume>45</volume>
                <fpage>793</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">7723972</pub-id>
              </element-citation>
            </ref>
            <ref id="sca2.REF.freund.2007.732">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Freund</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barnikol</surname>
                    <given-names>UB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nolte</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Treuer</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auburger</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tass</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Samii</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sturm</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Subthalamic-thalamic DBS in a case with spinocerebellar ataxia type 2 and severe tremor-A unusual clinical benefit.</article-title>
                <source>Mov Disord.</source>
                <volume>22</volume>
                <fpage>732</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">17265523</pub-id>
              </element-citation>
            </ref>
            <ref id="sca2.REF.furtado.2002.1625">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Furtado</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuboi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klimek</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de la Fuente-Fernandez</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hussey</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lockhart</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calne</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suchowersky</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoessl</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wszolek</surname>
                    <given-names>ZK</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>SCA-2 presenting as parkinsonism in an Alberta family: clinical, genetic, and PET findings.</article-title>
                <source>Neurology</source>
                <volume>59</volume>
                <fpage>1625</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12451209</pub-id>
              </element-citation>
            </ref>
            <ref id="sca2.REF.geschwind.1997b.842">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Geschwind</surname>
                    <given-names>DH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perlman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Figueroa</surname>
                    <given-names>CP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Treiman</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pulst</surname>
                    <given-names>SM</given-names>
                  </name>
                </person-group>
                <year>1997b</year>
                <article-title>The prevalence and wide clinical spectrum of the spinocerebellar ataxia type 2 trinucleotide repeat in patients with autosomal dominant cerebellar ataxia.</article-title>
                <source>Am J Hum Genet</source>
                <volume>60</volume>
                <fpage>842</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">9106530</pub-id>
              </element-citation>
            </ref>
            <ref id="sca2.REF.geschwind.1997a.1247">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Geschwind</surname>
                    <given-names>DH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perlman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Figueroa</surname>
                    <given-names>KP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karrim</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baloh</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pulst</surname>
                    <given-names>SM</given-names>
                  </name>
                </person-group>
                <year>1997a</year>
                <article-title>Spinocerebellar ataxia type 6. Frequency of the mutation and genotype- phenotype correlations.</article-title>
                <source>Neurology</source>
                <volume>49</volume>
                <fpage>1247</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">9371902</pub-id>
              </element-citation>
            </ref>
            <ref id="sca2.REF.huynh.2000.44">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Huynh</surname>
                    <given-names>DP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Figueroa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoang</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pulst</surname>
                    <given-names>SM</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human.</article-title>
                <source>Nat Genet</source>
                <volume>26</volume>
                <fpage>44</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">10973246</pub-id>
              </element-citation>
            </ref>
            <ref id="sca2.REF.huynh.2009.e6235">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Huynh</surname>
                    <given-names>DP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maalouf</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silva</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schweizer</surname>
                    <given-names>FE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pulst</surname>
                    <given-names>SM</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Dissociated fear and spatial learning in mice with deficiency of ataxin-2.</article-title>
                <source>PLoS One.</source>
                <volume>4</volume>
                <fpage>e6235</fpage>
                <pub-id pub-id-type="pmid">19617910</pub-id>
              </element-citation>
            </ref>
            <ref id="sca2.REF.huynh.2003.1485">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Huynh</surname>
                    <given-names>DP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>HT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vakharia</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nguyen</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pulst</surname>
                    <given-names>SM</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Expansion of the polyQ repeat in ataxin-2 alters its Golgi localization, disrupts the Golgi complex and causes cell death.</article-title>
                <source>Hum Mol Genet</source>
                <volume>12</volume>
                <fpage>1485</fpage>
                <lpage>96</lpage>
                <pub-id pub-id-type="pmid">12812977</pub-id>
              </element-citation>
            </ref>
            <ref id="sca2.REF.imbert.1996.285">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Imbert</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saudou</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yvert</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devys</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trottier</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garnier</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandel</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cancel</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abbas</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Durr</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Didierjean</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stevanin</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Agid</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats.</article-title>
                <source>Nat Genet</source>
                <volume>14</volume>
                <fpage>285</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">8896557</pub-id>
              </element-citation>
            </ref>
            <ref id="sca2.REF.infante.2004.848">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Infante</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berciano</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Volpini</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corral</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Polo</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pascual</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Combarros</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Spinocerebellar ataxia type 2 with Levodopa-responsive parkinsonism culminating in motor neuron disease.</article-title>
                <source>Mov Disord</source>
                <volume>19</volume>
                <fpage>848</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">15254952</pub-id>
              </element-citation>
            </ref>
            <ref id="sca2.REF.kiehl.2006.17">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kiehl</surname>
                    <given-names>TR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nechiporuk</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Figueroa</surname>
                    <given-names>KP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keating</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huynh</surname>
                    <given-names>DP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pulst</surname>
                    <given-names>SM</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Generation and characterization of Sca2 (ataxin-2) knockout mice.</article-title>
                <source>Biochem Biophys Res Commun</source>
                <volume>339</volume>
                <fpage>17</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">16293225</pub-id>
              </element-citation>
            </ref>
            <ref id="sca2.REF.lee.2003.858">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>WY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jin</surname>
                    <given-names>DK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oh</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Song</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chung</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Frequency analysis and clinical characterization of spinocerebellar ataxia types 1, 2, 3, 6, and 7 in Korean patients.</article-title>
                <source>Arch Neurol</source>
                <volume>60</volume>
                <fpage>858</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">12810491</pub-id>
              </element-citation>
            </ref>
            <ref id="sca2.REF.liu.2009.9148">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tang</surname>
                    <given-names>TS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nelson</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herndon</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huynh</surname>
                    <given-names>DP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pulst</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bezprozvanny</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 2.</article-title>
                <source>J Neurosci.</source>
                <volume>29</volume>
                <fpage>9148</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">19625506</pub-id>
              </element-citation>
            </ref>
            <ref id="sca2.REF.lorenzetti.1997.1009">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lorenzetti</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bohlega</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zoghbi</surname>
                    <given-names>HY</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>The expansion of the CAG repeat in ataxin-2 is a frequent cause of autosomal dominant spinocerebellar ataxia.</article-title>
                <source>Neurology</source>
                <volume>49</volume>
                <fpage>1009</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">9339681</pub-id>
              </element-citation>
            </ref>
            <ref id="sca2.REF.lu.2004.35">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu Chou</surname>
                    <given-names>YH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuo</surname>
                    <given-names>PC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chang</surname>
                    <given-names>HC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weng</surname>
                    <given-names>YH</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>The parkinsonian phenotype of spinocerebellar ataxia type 2.</article-title>
                <source>Arch Neurol</source>
                <volume>61</volume>
                <fpage>35</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">14732617</pub-id>
              </element-citation>
            </ref>
            <ref id="sca2.REF.mao.2002.338">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mao</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aylsworth</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Potter</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>WG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Breningstall</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wick</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Babovic-Vuksanovic</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nance</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patterson</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gomez</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Snow</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Childhood-onset ataxia: testing for large CAG-repeats in SCA2 and SCA7.</article-title>
                <source>Am J Med Genet</source>
                <volume>110</volume>
                <fpage>338</fpage>
                <lpage>45</lpage>
                <pub-id pub-id-type="pmid">12116207</pub-id>
              </element-citation>
            </ref>
            <ref id="sca2.REF.moretti.2004.392">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Moretti</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blazo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Armstrong</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lewis</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roa</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scaglia</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Spinocerebellar ataxia type 2 (SCA2) presenting with ophthalmoplegia and developmental delay in infancy.</article-title>
                <source>Am J Med Genet A.</source>
                <volume>124A</volume>
                <fpage>392</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">14735588</pub-id>
              </element-citation>
            </ref>
            <ref id="sca2.REF.moseley.1998.1666">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Moseley</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benzow</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schut</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gomez</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barkhaus</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blindauer</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Labuda</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pandolfo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koob</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ranum</surname>
                    <given-names>LP</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Incidence of dominant spinocerebellar and Friedreich triplet repeats among 361 ataxia families.</article-title>
                <source>Neurology.</source>
                <volume>51</volume>
                <fpage>1666</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">9855520</pub-id>
              </element-citation>
            </ref>
            <ref id="sca2.REF.orozco_diaz.1990.1369">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Orozco Diaz</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nodarse Fleites</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cordov&#x000e9;s Sagaz</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auburger</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>1990</year>
                <article-title>Autosomal dominant cerebellar ataxia: clinical analysis of 263 patients from a homogeneous population in Holgu&#x000ed;n, Cuba.</article-title>
                <source>Neurology</source>
                <volume>40</volume>
                <fpage>1369</fpage>
                <lpage>75</lpage>
                <pub-id pub-id-type="pmid">2392220</pub-id>
              </element-citation>
            </ref>
            <ref id="sca2.REF.orozco.1989.37">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Orozco</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Estrada</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perry</surname>
                    <given-names>TL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arana</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fernandez</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonzalez-Quevedo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Galarraga</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hansen</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1989</year>
                <article-title>Dominantly inherited olivopontocerebellar atrophy from eastern Cuba. Clinical, neuropathological, and biochemical findings.</article-title>
                <source>J Neurol Sci</source>
                <volume>93</volume>
                <fpage>37</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">2809629</pub-id>
              </element-citation>
            </ref>
            <ref id="sca2.REF.payami.2003.425">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Payami</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nutt</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gancher</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McNeal</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seltzer</surname>
                    <given-names>WK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hussey</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lockhart</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gwinn-Hardy</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singleton</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singleton</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hardy</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>SCA2 may present as levodopa-responsive parkinsonism.</article-title>
                <source>Mov Disord</source>
                <volume>18</volume>
                <fpage>425</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12671950</pub-id>
              </element-citation>
            </ref>
            <ref id="sca2.REF.pirker.2003.222">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pirker</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Back</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gerschlager</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laccone</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alesch</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Chronic thalamic stimulation in a patient with spinocerebellar ataxia type 2.</article-title>
                <source>Mov Disord</source>
                <volume>18</volume>
                <fpage>222</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">12539221</pub-id>
              </element-citation>
            </ref>
            <ref id="sca2.REF.pulst.1996.269">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pulst</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nechiporuk</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nechiporuk</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gispert</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>XN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopes-Cendes</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pearlman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Starkman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orozco-Diaz</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lunkes</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DeJong</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rouleau</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auburger</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korenberg</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Figueroa</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sahba</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2.</article-title>
                <source>Nat Genet</source>
                <volume>14</volume>
                <fpage>269</fpage>
                <lpage>76</lpage>
                <pub-id pub-id-type="pmid">8896555</pub-id>
              </element-citation>
            </ref>
            <ref id="sca2.REF.pulst.2005.2297">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pulst</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santos</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huynh</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Velazquez</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Figueroa</surname>
                    <given-names>KP</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Spinocerebellar ataxia type 2: polyQ repeat variation in the CACNA1A calcium channel modifies age of onset.</article-title>
                <source>Brain</source>
                <volume>128</volume>
                <fpage>2297</fpage>
                <lpage>303</lpage>
                <pub-id pub-id-type="pmid">16000334</pub-id>
              </element-citation>
            </ref>
            <ref id="sca2.REF.riess.1997.59">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Riess</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laccone</surname>
                    <given-names>FA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gispert</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schols</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zuhlke</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vieira-Saecker</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herlt</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wessel</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Epplen</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>BH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kreuz</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chahrokh-Zadeh</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meindl</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lunkes</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aguiar</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Macek</surname>
                    <given-names>M</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Krebsova</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Macek</surname>
                    <given-names>M</given-names>
                    <suffix>Sr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Burk</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tinschert</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schreyer</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pulst</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auburger</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>SCA2 trinucleotide expansion in German SCA patients.</article-title>
                <source>Neurogenetics</source>
                <volume>1</volume>
                <fpage>59</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">10735276</pub-id>
              </element-citation>
            </ref>
            <ref id="sca2.REF.r_b.2004.1258">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>R&#x000fc;b</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000fc;rk</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sch&#x000f6;ls</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunt</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Vos</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diaz</surname>
                    <given-names>GO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gierga</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghebremedhin</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schultz</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Del Turco</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mittelbronn</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auburger</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deller</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Braak</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Damage to the reticulotegmental nucleus of the pons in spinocerebellar ataxia type 1, 2, and 3.</article-title>
                <source>Neurology.</source>
                <year>2004</year>
                <volume>63</volume>
                <fpage>1258</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">15477548</pub-id>
              </element-citation>
            </ref>
            <ref id="sca2.REF.r_b.2005.127">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>R&#x000fc;b</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Del Turco</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burk</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diaz</surname>
                    <given-names>GO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auburger</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mittelbronn</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gierga</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghebremedhin</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schultz</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schols</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bohl</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Braak</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deller</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Extended pathoanatomical studies point to a consistent affection of the thalamus in spinocerebellar ataxia type 2.</article-title>
                <source>Neuropathol Appl Neurobiol</source>
                <volume>31</volume>
                <fpage>127</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">15771706</pub-id>
              </element-citation>
            </ref>
            <ref id="sca2.REF.r_b.2003.2257">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>R&#x000fc;b</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Del Turco</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Del Tredici</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Vos</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunt</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reifenberger</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seifried</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schultz</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auburger</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Braak</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Thalamic involvement in a spinocerebellar ataxia type 2 (SCA2) and a spinocerebellar ataxia type 3 (SCA3) patient, and its clinical relevance.</article-title>
                <source>Brain</source>
                <volume>126</volume>
                <fpage>2257</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">12847080</pub-id>
              </element-citation>
            </ref>
            <ref id="sca2.REF.sanpei.1996.277">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sanpei</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takano</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Igarashi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sato</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oyake</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sasaki</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wakisaka</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tashiro</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishida</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ikeuchi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koide</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saito</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sato</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanyu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takiyama</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishizawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nomura</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Segawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iwabuchi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eguchi</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuji</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT</article-title>
                <comment>[see comments]</comment>
                <source>Nat Genet</source>
                <volume>14</volume>
                <fpage>277</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">8896556</pub-id>
              </element-citation>
            </ref>
            <ref id="sca2.REF.sch_ls.1997a.924">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sch&#x000f6;ls</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amoiridis</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buttner</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Przuntek</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Epplen</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riess</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <year>1997a</year>
                <article-title>Autosomal dominant cerebellar ataxia: phenotypic differences in genetically defined subtypes?</article-title>
                <source>Ann Neurol</source>
                <volume>42</volume>
                <fpage>924</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">9403486</pub-id>
              </element-citation>
            </ref>
            <ref id="sca2.REF.sch_ls.1997b.1073">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sch&#x000f6;ls</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gispert</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vorgerd</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Menezes Vieira-Saecker</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blanke</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auburger</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amoiridis</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meves</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Epplen</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Przuntek</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pulst</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riess</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <year>1997b</year>
                <article-title>Spinocerebellar ataxia type 2. Genotype and phenotype in German kindreds.</article-title>
                <source>Arch Neurol</source>
                <volume>54</volume>
                <fpage>1073</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">9311350</pub-id>
              </element-citation>
            </ref>
            <ref id="sca2.REF.shibata.2000.1303">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shibata</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huynh</surname>
                    <given-names>DP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pulst</surname>
                    <given-names>SM</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>A novel protein with RNA-binding motifs interacts with ataxin-2.</article-title>
                <source>Hum Mol Genet</source>
                <volume>9</volume>
                <fpage>1303</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">10814712</pub-id>
              </element-citation>
            </ref>
            <ref id="sca2.REF.vel_zquezp_rez.2004.444">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vel&#x000e1;zquez-P&#x000e9;rez</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seifried</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santos-Falc&#x000f3;n</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abele</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ziemann</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Almaguer</surname>
                    <given-names>LE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mart&#x000ed;nez-G&#x000f3;ngora</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>S&#x000e1;nchez-Cruz</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Canales</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x000e9;rez-Gonz&#x000e1;lez</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vel&#x000e1;zquez-Manresa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Viebahn</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>von Stuckrad-Barre</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fetter</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klockgether</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auburger</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Saccade velocity is controlled by polyglutamine size in spinocerebellar ataxia 2.</article-title>
                <source>Ann Neurol.</source>
                <year>2004</year>
                <volume>56</volume>
                <fpage>444</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">15349876</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="sca2.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="sca2.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>12 November 2015 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>1 August 2013 me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>5 October 2010 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>25 January 2006 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>31 October 2003 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>13 January 2001 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>23 October 1998 (pb) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>2 March 1998 (smp) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
